Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,580.82 859.20 216.82 -84.52 41.47 0.00 19.3127 -0.39 -1.1297 -24.9898 -0.09 -0.08 7.5877 - -
Maximum - - - - - - 475,026.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Ultragenyx Pharmaceutical Inc. RARE 50.36 -0.07 -0.14% 1,230 vs. 686 4,641.00 108.00 -170.00 -203.00 -3,558.00 -2.0300 -5.7986 0.0000 0.7576 -1.5683 -1.2169 -0.1306 2.1127 92.00
Apellis Pharmaceuticals, Inc. APLS 29.98 1.24 4.31% 4,070 vs. 2,360 3,650.00 172.00 -66.00 -133.00 -2,903.00 -0.5400 -27.6326 0.0000 0.8802 -0.3855 -0.2491 -0.0798 2.7985 121.00
Halozyme Therapeutics, Inc. HALO 60.98 1.33 2.23% 1,025 vs. 1,369 7,758.00 195.00 76.00 125.00 167.00 0.6100 17.0691 0.0000 0.7647 0.3922 0.4321 0.0417 5.0088 127.00
Insmed Incorporated INSM 73.54 1.85 2.58% 1,047 vs. 1,724 13,156.00 75.00 -157.00 -188.00 -3,603.00 -1.0600 -6.3128 0.0000 0.7521 -2.0807 0.3380 -0.1355 1.5038 178.00
Revolution Medicines, Inc. RVMD 60.44 1.34 2.27% 1,740 vs. 1,118 10,095.00 0.00 -116.00 -163.00 -1,253.00 -0.7000 -11.2467 0.0000 0.0000 0.0000 -0.0672 -0.0608 18.1763 167.00
Akero Therapeutics, Inc. AKRO 34.45 -0.42 -1.20% 791 vs. 505 2,391.00 0.00 -53.00 -35.00 -627.00 -0.9000 -6.6902 0.0000 0.0000 0.0000 -0.0630 -0.0585 29.8643 69.00
Cerevel Therapeutics Holdings, Inc. CERE 44.96 0.33 0.74% 15,033 vs. 2,056 8,191.00 0.00 -131.00 -119.00 -1,532.00 -0.7300 -14.5661 0.0000 0.0000 0.0000 -0.2337 -0.1170 10.1215 182.00
Blueprint Medicines Corporation BPMC 100.83 -0.56 -0.55% 609 vs. 611 6,405.00 96.00 89.00 -102.00 -2,250.00 1.4500 16.6530 0.0000 0.9168 0.9274 0.2869 0.0858 3.4266 63.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for INSM and its peers to uncover potential buy and sell opportunities.